MeSH Browser

MeSH Supplementary: MEC protocol 2
Unique ID: C091013
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C091013
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Methotrexate; Epirubicin
Frequency: 6
Note: chemotherapy protocol consisting of above compounds; used in the treatment of bladder cancer
Source: Cancer Chemother Pharmacol 1994;35 Suppl:S9-13
Date of Entry: 1995/01/17
Revision Date: 2000/11/30

MEC protocol 2 MeSH Supplementary Concept Data 2024